Showing results (191-200 of 261) with videos related to
Sort By:
Pageof 27
World Journal of Gastroenterology|November 3, 2025
SinglePass Kronos electrocautery device for closure after percutaneous medical liver biopsy: Five case reportsAlexander S Misono, Behroz Oftadeh, Vincent Nguyen, et al.Air Medical Journal|December 9, 2022
Neonatal Vital Sign Trajectories and Risk Factors During Transport Within a Regional Care NetworkNancy D Greene, Taylor Riley, Rossella Mastroianni, et al.Journal of Drugs in Dermatology : JDD|April 14, 2021
Effect of Ixekizumab on Patient Reported Outcomes and Quality of Life in Patients With Moderate-to-Severe Plaque Psoriasis: 5-Year Results from the UNCOVER-1 and -2 StudiesMelinda J Gooderham, Boni Elewski, Matthias Augustin, et al.Obstetric Medicine|May 25, 2026
A woman with homozygous familial hypercholesterolaemia requiring lipoprotein apheresis and coronary artery bypass graft in pregnancyStephanie Smith, Emad AlJaaly, Christopher Baker, et al.Kidney Medicine|February 2, 2026
SinglePass Kronos Electrocautery Device for Closure After Percutaneous Medical Kidney Biopsy: A Series of Five Case ReportsAlexander S Misono, Tust Techasith, Avinash Mesipam, et al.The British Journal of Dermatology|March 27, 2023
Bimekizumab maintenance of response through 3 years in patients with moderate-to-severe plaque psoriasis: results from the BE BRIGHT open-label extension trialBruce Strober, Yayoi Tada, Ulrich Mrowietz, et al.Environmental Microbiology|November 18, 2022
Characterization of the molecular mechanisms of silicon uptake in coccolithophoresSarah Ratcliffe, Erin M Meyer, Charlotte E Walker, et al.Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2009
Effect of elective coronary angiography on glomerular filtration rate in patients with advanced chronic kidney diseaseNicola Kumar, Lynn Dahri, Wendy Brown, et al.The Australasian Journal of Dermatology|November 23, 2024
Australasian hidradenitis suppurativa management guidelinesJohn Frew, Annika Smith, Pablo Fernandez Penas, et al.Journal of the American Academy of Dermatology|April 5, 2023
Malignancy rates through 5 years of follow-up in patients with moderate-to-severe psoriasis treated with guselkumab: Pooled results from the VOYAGE 1 and VOYAGE 2 trialsAndrew Blauvelt, Mark Lebwohl, Richard G Langley, et al.Pageof 27